Nanotechnology Drug Delivery Market in the US 2012-2016

1

• Nanotechnology Drug Delivery Market in
  the US 2012-2016
  Bharat
  Book Bureau

2
Summary

• TechNavio's analysts forecast the
  Nanotechnology Drug Delivery market in the US to
  grow at a CAGR of 84.79 percent over the period
  2012-2016. One of the key factors contributing to
  this market growth is the low R and D cost. The
  Nanotechnology Drug Delivery market in the US has
  also been witnessing the trend of emergence of
  personalized medicines. However, the increasing
  safety concerns could pose a challenge to the
  growth of this market.The Nanotechnology Drug
  Delivery Market in the US 2012-2016, has been
  prepared based on an in-depth market analysis
  with inputs from industry experts. It also covers
  the Nanotechnology Drug Delivery market in the US
  landscape and its growth prospects in the coming
  years. The report also includes a discussion of
  the key vendors operating in this market.

3
Continue

• Key vendors dominating this space include
  Alkermes plc.,Celgene Corp., Novartis AG and
  SkyePharma plc .Other vendors mentioned in the
  report are Merck and Co. Inc., Pfizer Inc.,
  AlphaRx Inc., Amgen, Inc., Angiotech
  Pharmaceuticals, Inc., Biophan Technologies,
  Inc., Calando Pharmaceuticals, Inc., Cephalon,
  Inc., Cerulean Pharma, Inc, Copernicus
  Therapeutics, Inc., CritiTech, Inc., CytImmune
  Sciences, Inc., Elan Corporation, plc, Debiotech
  SA, F. Hoffmann-La Roche Ltd, Nano Interface
  Technology, Inc, Spherics, Inc., Spectrum
  Pharmaceuticals, Inc., SoluBest Ltd., Sigma-Tau
  Pharmaceuticals, Inc., PharmaNova Inc. Particle
  Sciences, Inc., Novavax, Inc., Nanotherapeutics,
  Inc., NanoSight Ltd., NanoCarrier Co. Ltd.,
  NanoBioMagnetics, Inc., Nano Interface
  Technology, Inc, Merck Sharp and Dohme Corp.,
  Kuecept Ltd., Izon Science Ltd.

4
Continue

• Key questions answered in this reportWhat
  will the market size be in 2016 and at what will
  be the growth rate?What are key market
  trends?What is driving this market?What are the
  challenges to market growth?Who are the key
  vendors in this market space?What are the market
  opportunities and threats faced by key
  vendors?What are the strengths and weaknesses of
  each of these key vendors?

5
Table of Contents

• 01. Executive Summary02. List of
  Abbreviations03. Introduction04. Scope of the
  ReportMarket Overview05. Market
  Landscape05.1Nanotechnology Drug Delivery Market
  in the USMarket Size and Forecast05.2Global
  Nanotechnology Drug Delivery Market
  Segmentation05.3Five Force Analysis06. Vendor
  Landscape07. Buying Criteria08. Market Growth
  Drivers09. Drivers and their Impact10. Market
  Challenges

6
Continue

• 11. Impact of Drivers and Challenges12.
  Market Trends13. Key Vendor Analysis13.1
  Alkermes plcBusiness OverviewKey
  InformationSWOT Analysis13.2 Celgene Corp.
  Business Overview Key InformationSWOT
  Analysis13.3 SkyePharma plcBusiness
  OverviewSWOT Analysis13.4 Novartis AGBusiness
  Overview Key InformationSWOT Analysis14. Other
  Reports in this Series

7
For More Information Kindly Visit On-

• http//www.bharatbook.com/healthcare-market-r
  esearch-reports/nanotechnology-drug-delivery-marke
  t-in-the-us-2012-2016.html
• Or visit us at
  Bharat Book Bureau
• Phone 91
  22 27810772, 27810773
• Toll Free
  No for USA/Canada 1-866-279-8368
• E-mail
  info_at_bharatbook.com
• Website
  www.bharatbook.com
• Twitter
  https//twitter.com/BharatBook
• Blog
  http//blog.bharatbook.com/